These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31041514)

  • 1. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
    Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density among Palestinian patients suffering from hemoglobinopathy disorders.
    Kharroubi A; Karmi B; Shamasneh W; Saba E
    Arch Osteoporos; 2020 Nov; 15(1):181. PubMed ID: 33188480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
    Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
    Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes.
    Mahachoklertwattana P; Pootrakul P; Chuansumrit A; Choubtum L; Sriphrapradang A; Sirisriro R; Rajatanavin R
    J Bone Miner Metab; 2006; 24(2):146-52. PubMed ID: 16502122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
    Doulgeraki A; Fragodimitri C; Athanasopoulou H; Drakaki K; Karabatsos F; Schiza V; Yousef J; Monopolis I; Chatziliami A
    Hemoglobin; 2021 Jan; 45(1):30-36. PubMed ID: 33557624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in children and young adults with beta-thalassemia trait.
    Mahachoklertwattana P; Chuansumrit A; Choubtum L; Sriphrapradang A; Sirisriro R; Rajatanavin R
    J Pediatr Endocrinol Metab; 2002; 15(9):1531-5. PubMed ID: 12503861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.
    Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R
    Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
    Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
    Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
    J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies.
    Di Paola A; Marrapodi MM; Di Martino M; Giliberti G; Di Feo G; Rana D; Ahmed S; Argenziano M; Rossi F; Roberti D
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia.
    Voskaridou E; Plata E; Douskou M; Sioni A; Mpoutou E; Christoulas D; Dimopoulou M; Terpos E
    Ann Hematol; 2011 Jan; 90(1):11-5. PubMed ID: 20661572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
    Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
    Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell/β-thalassemia: Comparison of Sβ
    Benites BD; Bastos SO; Baldanzi G; Dos Santos AO; Ramos CD; Costa FF; Gilli SC; Saad ST
    Hematology; 2016 Dec; 21(10):623-629. PubMed ID: 27237196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The instability of the membrane skeleton in thalassemic red blood cells.
    Yuan J; Bunyaratvej A; Fucharoen S; Fung C; Shinar E; Schrier SL
    Blood; 1995 Nov; 86(10):3945-50. PubMed ID: 7579365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sickle cell syndrome. Association between hemoglobin S and β thalassemia].
    Gasparini NP; Agriello EE; Zanella MJ; Iommi MP; Maradei J; Sandoval MJ
    Medicina (B Aires); 2016; 76(6):369-372. PubMed ID: 27959846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.